×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
HemoSonics' Quantra® Hemostasis System
Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot
Dr. Jonathan Sadeh, ex-SVP of Immunology R&D at Bristol-Myers Squibb, joins Scinai Immunotherapeutics' Scientific Advisory Board
BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog®
Vaxxas begins a Phase I clinical trial for an H7N9 influenza vaccine using its high-density microarray patch (HD-MAP)
Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time
UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.
nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.
Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research
FDA approves Bristol Myers Squibb's COBENFY™, a novel treatment for adult schizophrenia.
Featured Press Releases
BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog®
Orthofix Receives FDA 510(k) Clearance for Rodeo™ Telescopic Nail
09 May 2024
Orthofix Medical Inc. a leading global spine and orthopedics company, today announced that it has
...
Axion BioSystems Adds Affordable Maestro Volt™ to its Industry-Leading MEA System Lineup
Renibus Therapeutics to Present RBT-1 at European Association for Cardio-Thoracic Surgery
Repare Therapeutics announces promising Phase 1 data showing the effectiveness of Camonsertib in combination with radiotherapy treatment
Aileron Therapeutics will present Phase 1b trial data on low-dose LTI-03 for IPF at the 22nd International Colloquium on Lung and Airway Fibrosis
Isotopia collaborates with LIVEKIDNEY.BIO, marking a breakthrough in lupus treatment advancements
By
Isotopia
Isotopia
12 Dec 2024
ADC Therapeutics shares promising initial LOTIS-7 trial data on ZYNLONTA® combined with a bispecific antibody for relapsed/refractory DLBCL.
By
ADC Therapeutics SA
ADC Therapeutics SA
11 Dec 2024
MM+M honors Petauri's Nicole Lodowski as a 2025 40 Under 40 awardee
By
Petauri
Petauri
11 Dec 2024
Pilatus Biosciences Inc. earns FDA Orphan Drug Designation for PLT012, targeting liver and intrahepatic bile duct cancer
By
Pilatus Biosciences
Pilatus Biosciences
10 Dec 2024
Biolexis Therapeutics reports positive outcomes for BLX-7006 in an expanded Diet-Induced Obesity (DIO) model study
By
Biolexis Therapeutics Inc
Biolexis Therapeutics Inc
09 Dec 2024
UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors
By
UroMems
UroMems
06 Dec 2024
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Eisai strengthens its presence in Saudi Arabia by establishing a new pharmaceutical sales subsidiary to enhance its operations in the region
By
Eisai
Oct 09
Onconic Therapeutics gets MFDS nod for JAQBO, a fresh remedy for Gastroesophageal Reflux Disease
By
onconic Therapeutics
Apr 25
Neurophet gains FDA 510(k) clearance for Neurophet AQUA, advancing multiple sclerosis analysis with AI-driven precision
By
Neurophet
Nov 25
December
2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe for e-Newsletter Monthly
Subscribe to the Pharmaceutical Era newsletter to receive timely updates from your favorite products.
Email
I consent to subscribing to the selected email lists.
Enter the code below
Subscribe
1
